OTC Drug Office Proposal Aimed At Balancing Funds, Workload
This article was originally published in The Rose Sheet
Executive Summary
The creation of an FDA Office of Non-Prescription Products is part of a proposed reorganization of the Center for Drug Evaluation & Research Office of New Drugs seeking to balance allocation of resources with the office's workload, according to a proposal by OND Director John Jenkins, MD, released by the agency Oct. 28
You may also be interested in...
Crawford’s White House Valentine Enclosed With FDA Nomination
FDA Acting Commissioner Lester Crawford, PhD/DVM, has been nominated to fill the position permanently, the White House announced Feb. 14
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program